The density of a2-adrenoceptors, using 3H-idazoxan as the radioligand, was determined by quantitative lUtoradiography in the locus coeruleus and in 13 noradrenergic projection fields following chronic Idministration of drugs acting on noradrenergic and/or StTOtonergic neurons. Protriptyline, an inhibitor of the JlPfake of norepinephrine, and mianserin, an al'lUirenoceptor antagonist, reduced the binding of lH·idazoxan only in the locus coeruleus. Phenelzine, an inhibitor of both type A and type B monoamine oxidase (MAO), reduced the binding of 3H-idazoxan in the locus CM'II leus and in several areas with noradrenergic innervation from tegmental cell bodies. Clorgyline, a stltctive inhibitor of type A MAO, had no effect. Of the trro selective inhibitors of serotonin uptake, citalopram lEY WORDS: a2-adrenoceptors; 3H-Idazoxan; Locus uxruleus: Antidepressants
caused a modest increase in binding only in one terminal field area, whereas sertraline had no effect. Although these antidepressants did not produce consistent effects on a2-adrenoceptors, protriptyline, mianserin, and phenelzine were similar in that they all decreased the binding of 3H-idazoxan in the locus coeruleus without widely affecting its binding in the coerulean terminal fields. Deprenyl, a selective inhibitor of type B MAO, the only drug in this study without proven antidepressant efficacy, differed from all other drugs in that it decreased the binding of 3H-idazoxan both in the locus coeruleus as well as in most terminal fields with primarily coerulean noradrenergic innervation. [NeuTopsychopharmacology 8:57-65, 1993J When given repeatedly, antidepressant drugs produce multiple effects on noradrenergic and serotonergic neu rons and receptors (see Heninger and Charney 1987; Frazer et al. 1988) . Recent autoradiographic studies identified specific regions of the brain where effects on l3-adrenergic receptors by these drugs are most promi nent (Ordway et al. 1991) . There has been considerable interest in the response of a-adrenoceptors to chronic administration of antidepressants. Some a2-adreno ceptors in the brain are situated in the projection ftelds of noradrenergic neurons, where they modulate the re lease of norepinephrine as presynaptic autoreceptors (Langer 1977; Starke 1981) , whereas others act as post synaptic receptors (U'Prichard et al. 1977) . A number of studies found a decrease in the density of these recep tors following chronic administration of antidepressant drugs, but other studies found no effect (Pile 1987) .
Alpha2-adrenoceptors are also found in the locus coeruleus. These somatodendritic adrenoceptors exert an inhibitory effect on the fIring of the noradrenergic neurons of the locus coeruleus (Svensson et a1. 1975; Cedarbaum and Aghajanian 1976) , which have wide spread axonal projections throughout the brain. To the best of our knowledge no study has dealt with the effect of different types of antidepressant drugs on the den sity of o.2-adrenoceptors in this cell body area. How ever, a number of studies have dealt with the effect of repeated administration of antidepressant drugs on the spontaneous and evoked electrical activity of the locus coeruleus (Scuvee-Moreau and Svensson 1982; Blier and de Montigny 1985; Campbell et al. 1985; Curtis and Valentino 1991) . These studies showed that whereas some antidepressants do cause changes in locus coeruleus fIring or the response of these cells to 0.2-adrenoceptor agonists, others do not produce such effects.
The present study examined the effect of repeated administration of antidepressant drugs on the binding of 3H-idazoxan, a highly selective o.2-adrenoceptor an tagonist (Chapleo et al. 1981; Dettmar et al. 1983) , to o.2-adrenoceptors in the locus coeruleus and in the ter minal fIelds of coerulean neurons. The measurements were obtained using the technique of quantitative recep tor autoradiography, the best available method for measuring receptors in discrete regions of the brain (Ku har 1985) .
MATERIALS AND METHODS

Animals
Male Sprague-Dawley rats (weighing between 200 and 225 g) were purchased from Ace Animals (Boyertown, PA) and housed in clear polycarbonate cages in groups that did not exceed four animals per cage. The rats re ceived Purina Rodent Lab Chow #5001 (Purina Corp., St. Louis, Missouri) and tap water ad libitum. Light in the animal quarters was regulated on a 12-hour light/dark cycle with the room being dark from 1800 hours until 0600 hours. Table 1 shows the dose, route, and schedule of adminis tration for each drug used in this study. The drugs, whose concentrations are expressed as the free base, were dissolved in distilled water so as to permit injec tion of a volume of 0.1 ml/l00 g of body weight for all drugs except for mianserin and sertraline, which were injected in a volume of 0.2 ml/l00 g of body weight.
Administration of Drugs
NEUROPSYCHOPHARMACOLOGY 199 3 -VOL. 8, NO.1 Animals treated once a day were injected between 0900 and 0930 hours, whereas those treated twice a day re ceived their injections at 0900 to 0930 and at 1600 to 1630 hours. Dose schedules were selected either because they caused alterations in �-adrenoceptors (Ordwayet a1. 1991), or produced serotonergic autoreceptor sub sensitivity (Blier and de Montigny 1985; Chaput et al 1986) . The regimens for clorgyline and deprenyl are selective for type A and type B monoamine oxidase (MAO), respectively Oohnstone 1968; Campbell et al. 1979; Eckstedt et al. 1979) . The doses of sertraline 01 protriptyline have been shown to block in vivo the up take of serotonin (5-HT) (Wolfe et al. 1987) or norepi· nephrine (Schildkraut et al. 1971) , respectively.
Preparation of Tissue Sections
Rats were euthanized by decapitation between 1000 and 1100 hours the morning after receiving their last injec· tion of drug or saline (i.e., 18 to 25 hours after the £mal injection). The brains were removed, rinsed in ice-cold saline, and frozen on powdered dry ice. The frozen tis· sue was stored at -80aC until sectioning. From each brain, two sets of coronal sections were cut 20 J.Lm in thickness in a cryostat at -15aC. One set of sections was cut at the level of the dorsomedial hypothalamic nucleus and the other was cut in the mid-level of the locus coeruleus. The sections were thaw mounted onto gelatin-coated frozen microscope slides and dehydrated overnight at 4°C. Several sections from each seriall y cut set were stained with thionin and examined under a light microscope to establish their position along the rostral-caudal axis, using the stereotaxic atlas by Pax· inos and Watson (1986) as reference. With the aid of these stained sections the rostral and caudal limits of Figure 29 of the atlas were identifIed. By a similar pro cess, the rostral and caudal limits of Figure 58 of the atlas, showing the most densely packed cells of the lo cus coeruleus, were bracketed. Two to four sections at each level were incubated.
Incubation Procedure
In preparation for incubation, the sections were trans· ferred from a freezer at -80aC to a desiccator at 4°( for temperature equilibration. The incubation procedure was performed essentially as described by Boyajian et a1. (1987) and Chamba et al. (1991) . First, the sections were preincubated at room temperature in buffer (58 mmollL Na2HP04, 8.5 mmollL KH2P04, pH 7.4) for 15 minutes. Incubation was carried out at 4°C for 2 hours in buffer containing 3.0 nmollL 3H-idazoxan (42) (43) (44) (45) (46) (47) (48) (49) (50) (51) (52) (53) Ci/mmol, Amersham Corp., Arlington Heights, IL).A maximum of fIve slides, containing two sections each, were placed in 30 ml of incubation medium in polyeth· ylene Coplin jars. Upon completion of incubation, the 
Quantitative Autoradiography
The dried, slide mounted sections were placed into spring-loaded metal x-ray cassettes along with plastic embedded tritium standards (American Radiolabelled Chemicals, St. Louis, MO), previously calibrated against brain mash standards according to the method de scribed earlier (Geary and Wooten 1983; Geary et al. 1985) , and apposed at room temperature to tritium sen sitive &lm (Ultro&lm 3H, Cambridge Instruments, Gaithersburg, MD). Sections containing the locus coeruleus were exposed for 28 days and those show ingterminal fIeld areas were exposed for 49 days. The exposed fIlms were processed using Kodak GBX de veloper and fIxer. The autoradiograms were analyzed on a DUMAS (Drexel Unix based Microcomputer Im age Analysis System) densitometer using the BRAIN software package (Feingold et al. 1986 ). The incubated sections were subsequently stained with thionin to facilitate identiftcation of neuroanatomic structures that were defined and named according to the atlas of Pax inos and Watson (1986).
Statistical Methods
The samples were analyzed blind and identifted by ran domly chosen code numbers. The data were examined by analysis of variance (Sokal and Rohlf 1969) , and in dividual groups were compared to the control group by Dunnett's test (Zar 1984) . P values of less than 0.05
were considered signifIcant. In competition experi ments the data were analyzed using a nonlinear leastsquares parametric curve fItting program (Sigmaplot 4.0, J andel ScientifIc, Corte Madera, CA). One-site and two-site models were compared using a Fisher ratio (F) computed as follows:
where 551 and 552 are the error sum of squares for the one-site model and two-site model, respectively; dfss1
and dfss2 are the degrees of freedom for the one-site and two-site models. The two-site model is accepted as a signifIcantly better fIt than the one-site model when the value of F is greater than or equal to the tabulated value at the given degrees of freedom and the proba bility of a type I error of 0.05.
Drugs
The antidepressants used in this study were citalopram 
RESULTS
The radioligand 3H-idazoxan is a highly selective a2-adrenoceptor antagonist (Chapleo et al. nmollL, the same as that in the subsequent experi ments. Figure 1A shows the results of competition experiments with the adrenergic antagonists phentola mine, prazosin, SKF-104375, and the physiologic neu rotransmitter ( -)norepinephrine in the locus coeruleus.
These drugs were selected as they do diff erentiate a2-adrenergic from non-a2-adrenergic binding sites of 3H_
idazoxan (Michel et al. 1989) . It is evident from the il lustration that each drug displaced approximately 80% to 90% of total binding of 3H-idazoxan. Nonlinear regression analysis indicated that the displacement The effect of chronic administration of these drugs on the binding of 3H-idazoxan in terminal fIeld areas is summarized in Table 2 . In these structures, only deprenyl and phenelzine altered binding signifIcantly. In contrast to the ability of these inhibitors of MAO to decrease the binding of 3H-idazoxan both in the 10-
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cus coeruleus and in some terminal neld areas, mianse rin and protriptyline had no effect on the binding of this radioligand in projection nelds (Table 2) . Finally, citalopram produced a modest (8%), but statistically signiftcant increase in binding of 3H-idazoxan in the dorsal hypothalamic area, whereas sertraline and clor gyline had no statistically signiftcant effect in any of the terminal nelds examined (results not shown).
DISCUSSION
The radioligand 3H-idazoxan, with 10 IlmollL phen tolamine as the displacing agent to denne speciftc bind ing, has been used for quantitative autoradiographic measurement of az-adrenoceptors prior to this study Chamba et al. 1991) . Others speculated that, due to the pres ence of a nonstereoselective adrenergic binding site, the density of az-adrenoceptors may be overestimated by this method (Convents et al. 1989 ; Lehmann et al. 1989 ).
This speculation was based on measurements per formed on homogenates of human and rabbit cortex (Convents et al. 1989) in the presence of a buffer con siderably different and at a concentration of 3H-ida zoxan signiftcantly higher than that used in the au toradiographic procedure. The displacement curve produced by phentolamine under those conditions was shallow and biphasic, and 10 IlmollL phentolamine only displaced approximately 40% of the total binding. This result is markedly diff erent from what we observed un der our assay conditions, using slide-mounted sections of rat brain and 3 nmol/L 3H-idazoxan. Both ( -)nore pinephrine, the physiologically active neurotransmit ter, and phentolamine produced steep monophasic dis placement curves and displaced 3H-idazoxan to the same extent: approximately 80% of the total binding in the locus coeruleus (Fig. lA) , and 70% to 80% of the total binding in the terminal fIelds (data not shown).
Also, 3H-idazoxan binds to a nonadrenergic (idazoxan)
receptor, in addition to u2-adrenoceptors, and in some tissues as much as 50% of the total binding by 3H-ida zoxan is to this nonadrenergic site (Michel et al. 1989; Brown et al. 1990; Wikberg and Uhlen 1990) . Certain adrenergic antagonists, such as phentolamine and prazosin, displace 3H-idazoxan only from u2-adreno ceptors, whereas others, such as SKF-I04078 and oxy metazoline, are capable of displacing 3H-idazoxan from both the u2-adrenoceptors as well as from the non adrenergic (idazoxan) receptor (Michel et al. 1989 ). 1989) . Taken together, these fIndings demonstrate that our assay conditions, using 3H-idazoxan and 10
IJ.mol/L phentolamine to defIne specifIc binding, are ap propriate for measurement of u2-adrenoceptors in the locus coeruleus and in the terminal fIelds at the level of the midbrain using slide-mounted sections.
Chronic administration of some of the antidepres sant drugs studied decreased the density of u2-adreno ceptors in the locus coeruleus. These drugs were pro triptyline, an inhibitor of the uptake of norepinephrine (Schildkraut et al. Our autoradiographic data are consistent with the electrophysiologic measurements in that chronic ad· ministration of protriptyline, which like imipramine and desipramine inhibits the uptake of norepinephrine, de creased the density of u2-adrenoceptors in the locus coeruleus. Furthermore, chronic administration of elOl' gylirie had no effect on either the sensitivity of locus coeruleus cells to clonidine (Blier and de Montigny 1981; Campbell et al. 1985) or on the binding of 3H-idazoxan in the locus coeruleus. On the other hand, whereas we found a modest decrease in the density of u2-adreno ceptors in the locus coeruleus after repeated adminis tration of phenelzine or deprenyl, similar treatmenb produced no changes in the response of the locus coeruleus to clonidine (Blier and de Montigny 1985) The daily dose of phenelzine in the latter study, how ever, was considerably lower than that used in our ex· periments. Both the electrophysiologic and the au toradiographic measurements indicate, nevertheless that the effects by different types of antidepressant drugs on the responsivity or density of u2-adreno ceptors in the locus coeruleus are not uniform.
Only two of the drugs, deprenyl and phenelzine produced substantial reductions in binding of 3H idazoxaJ) in noradrenergic terminal fIelds. Some of tm terminal fIelds examined in this study receive all of th� noradrenergic fIbers from the locus coeruleus, namelr' the parietal cortex, frontal cortex, retrosplenial cortex hindlimb area of the cortex, laterodorsal thalamic nu cleus, and basomedial amygdaloid nucleus. Other brain areas receive either mixed coerulean and noncoerulean (i.e., tegmental) noradrenergic innervation, or receive onl y noncoerulean noradrenergic innervation, namely the paraventricular thalamic nucleus, ventromedial hypothalamic nucleus, dorsal hypothalamic area, lateral hypothalamic area, and central amygdaloid nucleus (Lindvall and Bjorklund 1978; Moore and Card 1984; Aston-Jones et al. 1984) .
Deprenyl, an inhibitor of type B MAO, produced a distinctive pattern of effect in the nor adrenergic ter minal fIelds ( Table 2) : it reduced the binding of 3H-ida zoxan in seven of the eight areas of the brain with noradrenergic projections originating only from the lo cus coeruleus, whereas its effects were consistently smaller and were statistically not signifIcant in brain areas that receive noradrenergic innervation, either ex clusively or partially, from tegmental cell bodies. Phenelzine, an inhibitor of type A and type B MAO, decreased the binding of 3H-idazoxan primarily in those terminal fIeld areas where deprenyl had no effect, namely those that receive noradrenergic projections, ei ther exclusively or partially, from tegmental cell bod ies ( Table 2) . Given this, together with the fact that clor gyline, a type A MAO, had no effect, it is not clear how the effects on a2-adrenoceptors by deprenyl or phenel zine are related to inhibition of MAO.
Interestingly, phenelzine produced similar regional effects on �2-, but not on 131-adrenoceptors (Ordway et aI. 1991) , as on a2-adrenoceptors. Phenelzine de creased the binding of 12 5I-iodopindolol to �2-adreno ceptors in the habenular and paraventricular thalamic nuclei, which receive primarily non-coerulean inner vation, whereas it had no effect on 132-adrenoceptors in se ven thalamic nuclei that receive only coerulean noradrenergic fIbers according to Lindvall and Bjork lund (1978) . Phenelzine also caused a marked reduc tion in binding to �2-adrenoceptors in all three hypothalamic areas examined, the lateral hypothalamic area, the ventromedial, and dorsomedial hypothalamic nuclei, all of which receive predominantly tegmental noradrenergic fIbers (Moore and Card 1984) , but pro duced no effect on 132-adrenoceptors in cortical and hi ppocampal areas, which receive only coerulean noradrenergic fIbers (Loy et al. 1980; Moore and Card 1984) . There was only one exception to this pattern, and, as in our study, it occurred in the amygdala: phenel zine reduced the binding to 132-adrenoceptors in the medial amygdaloid nucleus, which receives coerulean noradrenergic innervation according to Moore and Card (1984) .
Since there appears to be no evidence to the con trary, it is assumed that 3H-idazoxan binds to both pres ynaptic and postsynaptic a2-adrenoceptors. Since postsynaptic a2-adrenoceptors, in general, SignifIcantly 3 H-Idazoxan Binding and Antidepressants 63 outnumber the presynaptic ones (Greenberg et al. 1976; V'Prichard et al. 1977) , it is likely that our results with 3H-idazoxan in terminal fIeld areas r e present binding predominantly to postsynaptic a2-adrenoceptors. The a2-adrenoceptor population has been divided into at least two subtypes, a2A-and a2s-adrenoceptors, based on their pharmacologic properties (Bylund et al. 1988) . Our competition experiments, involving the locus coeruleus (Fig. 1A ) and terminal fIelds at the level cor responding to Figure 29 of the atlas by Paxinos and Wat son (1986) , indicate that 3H-idazoxan binds to a single population of a2-adrenoceptors. Further studies are needed to determine whether these adrenoceptors are of the a2A or a2B subtypes.
In conclusion, whereas some antidepressants in this study showed no effect, others produced modest decreases in a2-adrenoceptors in distinctive regional patterns. Further studies are needed to examine the signifIcance of these fIndings with regard to the mech anism of action of antidepressant drugs.
